SCHG Schwab U.S. Large-Cap Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 10.65% |
| AAPL | 9.16% |
| MSFT | 7.26% |
| AMZN | 5.35% |
| GOOGL | 4.26% |
| AVGO | 3.97% |
| GOOG | 3.41% |
| LLY | 2.98% |
| META | 2.59% |
| AMD | 2.44% |
ETF Analysis
Fund Overview
Schwab U.S. Large-Cap Growth ETF (SCHG) currently reports 194 stock positions (subject to change), placing it in the expansively diversified range by holdings breadth. The top line-up is NVDA (10.65%), AAPL (9.16%), MSFT (7.26%), with NVDA as the largest single weight at 10.65%. Together, the top three holdings account for 27.07%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.
Profitability & Capital Efficiency
From a returns-on-capital standpoint, ROIC is 47.50%, WACC is 11.10%, and the economic spread is 36.40%. On balance, the gap between ROIC and WACC places this portfolio among the more capital-efficient baskets available. Supporting metrics show ROE at 58.07% and ROA at 16.35%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
The market currently prices the portfolio at trailing P/E of 30.59, forward P/E of 26.35, PEG of 1.83. The gap between P/E and forward P/E is small, suggesting the valuation is not contingent on a near-term earnings step-change. The PEG ratio is consistent with a portfolio that is reasonably valued on a growth basis — not cheap, but not obviously expensive either. The aggregate current ratio of 1.97 points to adequate liquidity across holdings. Valuation and liquidity together frame a portfolio where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.
Margins & Cash Generation
On profitability at each income statement layer, gross margin sits at 59.71%, operating margin at 8.63%, and free cash flow margin at 26.76%. The portfolio's gross margins are solid, reflecting a reasonable balance between revenue realization and direct cost absorption. The operating margin reading is modest, consistent with businesses still working to scale their cost structures efficiently. Free cash flow conversion is outstanding — the portfolio's holdings are generating exceptional cash after capital expenditures. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.
Growth & Forward Outlook
Looking at growth and market-implied direction, TTM revenue growth of 30.62% indicating that revenue growth remains a meaningful tailwind for the portfolio. At the same time, the estimated 12-month price change of 18.71%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe composite of ROIC spread, valuation, revenue momentum, and analyst expectations delivers a rare alignment of quality and growth that justifies elevated conviction.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.